About Sagres Discovery
Sagres Discovery was a Healthcare company based in Davis (United States) founded in 2000 by David Ferrick. It creates innovative mouse models to analyze genes causing cancer diseases. It operates on a B2B model. Sagres Discovery has raised $20 million across 1 funding round from investors including CDIB Capital Group, Burrill and Company and Forward Ventures. Its chief executive, as recorded, is David Ferrick. Its website sagresdiscovery.com draws about 681 thousand monthly visits. The company is recorded as dissolved. Its focus areas include Biotechnology, Research and Development and Cancer Genetics. Its competitors include Biocytogen, Interius Biotherapeutics and Applied StemCell; 3 of its 3 listed competitors have raised funding.
Company details
Sagres Discovery creates innovative mouse models to analyze genes causing cancer diseases through providing healthcare solutions, advancing biotech innovations, research and development, and cancer genetics. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Davis, United States
- Founders David Ferrick
- SectorsHealthcare
- Website sagresdiscovery.com
- Total Equity Funding$20M (USD)
in 1 rounds
- Latest Funding Round$20M (USD), Series A
Oct 2001
- InvestorsCDIB Capital Group
& 6 more
Funding Insights of Sagres Discovery
Sagres Discovery has successfully raised a total of $20M through 1 strategic funding round. The most recent funding activity was a Series A round of $20 million completed in October 2001. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $20M
- Total Rounds 1
- Last Round Series A — $20M
- First Round $20M
(Oct 2001)
- Investors Count 7
All 1 funding rounds of Sagres Discovery with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2001 | $20M | Series A | – | Forward Ventures |
7 investors in total: 7 institutional.
Investors in Sagres Discovery
Sagres Discovery has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include CDIB Capital Group, Burrill and Company and Forward Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life Sciences focused VC firm that does early stage investments in the US | forwardventures.com | San Diego, United States | ||
| axiomventures.com | ||||
Investments are made in innovative life science companies globally. | nvfund.com | Basel, Switzerland | ||
Seed and early-stage investments are focused on US companies. | waldenvc.com | Woodside, United States | ||
Investments in early-stage tech startups are made by JAFCO Asia. | jafcoasia.com | Singapore, Singapore | ||
Sector-agnostic investments are made in early-stage Asia Pacific startups. | 1959 | cdibcapitalgroup.com | Taipei, Taiwan | |
Multi-category products are listed on an online B2B platform. | 1994 | burrillandco.com | Wuxi, China |
Investor details for Sagres Discovery
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sagres Discovery
1 people are tracked at Sagres Discovery (1 in leadership).
| Name | Role | Group |
|---|---|---|
David Ferrick | Founder, CEO | Leadership |
Complete people profiles for Sagres Discovery
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Sagres Discovery
2 dated milestones of Sagres Discovery across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Sagres Discovery is founded.
- Funding First funding round of $20.0M.
Competitors of Sagres Discovery
Sagres Discovery has 3 listed competitors in our database, 3 of them funded. They include Biocytogen, Interius Biotherapeutics and Applied StemCell.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biocytogen.com | 2008 | Wakefield, United States | $301.11M | 85 | Integrated solutions for next-generation antibody drug development are provided. | |
| interiusbio.com | 2020 | Philadelphia, United States | $129.03M | 25 | Developer of gene therapies for treating multiple diseases | |
| appliedstemcell.com | 2008 | Milpitas, United States | $67.52M | 53 | Provider of animal and cell line models as tools for drug discovery and diagnostics |
Detailed competitors of Sagres Discovery
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Sagres Discovery
The website of Sagres Discovery (sagresdiscovery.com) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with Sagres Discovery. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Sagres Discovery
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as Sagres Discovery (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sagres Discovery
Sagres Discovery was founded in 2000 and raised its 1st funding round 1 year after it was founded.
Sagres Discovery is headquartered in Davis, United States. It is registered at Davis, California, United States.
David Ferrick is the CEO of Sagres Discovery, as recorded in our data. They have also founded this company.
Sagres Discovery is a funded company, having raised a total of $20M across 1 funding round to date. The company's 1st funding round was a Series A of $20M, raised on Oct 2001.
Sagres Discovery creates innovative mouse models to analyze genes causing cancer diseases through providing healthcare solutions, advancing biotech innovations, research and development, and cancer genetics. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Sagres Discovery's top competitors include Biocytogen, Applied StemCell and Interius Biotherapeutics.
Sagres Discovery has 7 investors. Key investors include CDIB Capital Group, Burrill and Company, Forward Ventures, Axiom Venture Partners, and Novartis Venture Fund.
The website of Sagres Discovery receives about 681 thousand visits a month.